Our Pricing

Where To Buy Wegovy UK: Private Prescription Route

If you're wondering where to buy Wegovy UK private prescription, Cured Pharmacy offers a straightforward online service with UK-registered prescribers, transparent pricing from £79.00, and discreet next-day delivery. Our clinical team provides free consultations in under three minutes, making genuine UK-licensed semaglutide accessible without the lengthy NHS waiting lists.

How the Private Prescription Route Works for Wegovy

The private prescription pathway allows eligible UK patients to access Wegovy without waiting for NHS provision, which remains limited in many areas. At Cured Pharmacy, the process begins with a free online clinical assessment completed by our UK-registered prescribers, typically reviewed within hours of submission.

Once your prescriber approves your assessment—considering your BMI, medical history, and weight loss goals—your Wegovy prescription is issued and dispensed from our GPhC-registered pharmacy (registration number 9012511). All medications are genuine UK-licensed products sourced directly from authorised wholesalers, never grey-market imports.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure clinical appropriateness and patient safety. You'll receive your medication in 100% discreet packaging, with no external markings indicating contents, delivered to your chosen address across the UK.

Wegovy Pricing and What's Included

Wegovy is available at Cured Pharmacy from £79.00 per pen, with prices displayed upfront before you begin your consultation—no hidden fees or surprise charges at checkout. This transparent pricing model ensures you know exactly what you'll pay based on your prescribed dose.

Your Wegovy service includes the free clinical consultation, UK prescriber review, genuine UK-licensed medication, discreet packaging, and tracked delivery. Unlike some providers who add consultation fees or membership charges, our pricing covers the complete service from assessment to your doorstep.

We guarantee the lowest prices in the UK for genuine licensed medications. If you find a lower price elsewhere for the same product from a UK-registered pharmacy, we'll match it—that's our commitment to accessible weight management treatment.

Dose Escalation and Long-Term Costs

Wegovy follows a structured dose escalation schedule to minimise gastrointestinal side effects. You'll typically start at 0.25mg weekly, gradually increasing to the maintenance dose of 2.4mg over 16-20 weeks [1]. Your prescriber will guide you through this titration based on your tolerance and response.

Planning for long-term treatment costs is important, as clinical trials demonstrate Wegovy's effectiveness requires sustained use. In the STEP 1 trial, participants achieved an average 14.9% body weight reduction over 68 weeks at the 2.4mg maintenance dose [1]. Weight regain commonly occurs after discontinuation, so budgeting for ongoing treatment helps ensure lasting results.

Clinical Evidence: How Wegovy Delivers Results

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural gut hormone regulating appetite and food intake. By activating GLP-1 receptors in the brain, semaglutide reduces hunger signals and increases feelings of fullness, helping patients consume fewer calories without constant willpower battles [2].

The STEP clinical trial programme provides robust evidence for Wegovy's effectiveness. In STEP 1, adults with obesity who received 2.4mg semaglutide weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo [1]. Importantly, 86.4% of semaglutide participants achieved at least 5% weight loss—the threshold where health benefits begin—versus 31.5% on placebo.

Beyond weight reduction, STEP trials documented improvements in cardiovascular risk factors including blood pressure, lipid profiles, and inflammatory markers [2]. These metabolic benefits make Wegovy particularly valuable for patients with obesity-related comorbidities, though individual results vary and require ongoing prescriber monitoring.

Who Can Access Wegovy Through Private Prescription

The MHRA has licensed Wegovy for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidaemia [3]. Your UK prescriber will calculate your BMI during the online assessment and review your medical history to determine eligibility.

Certain medical conditions may preclude Wegovy use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Pregnancy and breastfeeding are also contraindications, as semaglutide's effects on foetal development haven't been established in human studies [3].

Our clinical team considers your complete health profile, including current medications that might interact with semaglutide. This thorough assessment ensures Wegovy is both safe and appropriate for your individual circumstances, with ongoing support available from our pharmacists throughout your treatment journey.

Starting Your Assessment

The online consultation takes under three minutes and covers essential health questions about your weight history, previous weight loss attempts, current medications, and relevant medical conditions. Honest, complete answers help our prescribers make safe, effective treatment decisions tailored to your needs.

You'll receive a response typically within hours during business days. If approved, your prescription is issued immediately and your Wegovy pens dispatched the same day for next-day delivery across most of the UK. If your prescriber identifies any concerns, they'll contact you directly to discuss alternative options or request additional information.

Managing Side Effects and Treatment Expectations

Gastrointestinal side effects are the most commonly reported with Wegovy, affecting approximately 44% of participants in clinical trials [1]. Nausea, diarrhoea, vomiting, and constipation typically occur during dose escalation and often diminish as your body adjusts to each new dose level.

Practical strategies can minimise these effects: eating smaller, more frequent meals; avoiding high-fat foods; staying well-hydrated; and allowing your prescriber to slow dose escalation if side effects prove troublesome. Most patients find symptoms manageable and temporary, though a small percentage discontinue treatment due to gastrointestinal intolerance.

Realistic expectations matter for treatment success. While clinical trials show impressive average results, individual responses vary considerably. Some patients exceed trial averages, while others experience more modest weight loss. Wegovy works best alongside sustainable dietary changes and increased physical activity—it's a powerful tool, not a standalone solution [2].

Why Choose Cured Pharmacy for Your Wegovy Prescription

As a fully registered UK pharmacy (GPhC 9012511), we're held to the same rigorous standards as any high-street pharmacy, with the added convenience of online access and competitive pricing. Our superintendent pharmacist oversees every aspect of your care, from prescription review to medication dispensing and patient support.

We stock only genuine UK-licensed Wegovy pens sourced through authorised channels, never grey-market or international versions that may lack UK regulatory approval. Each pen arrives with patient information leaflets, proper storage guidance, and access to our pharmacy team for any questions about administration or side effects.

Our lowest price guarantee, transparent upfront pricing, and discreet service have helped thousands of UK patients access weight management treatments that might otherwise remain out of reach. You're not just buying medication—you're gaining a clinical partner committed to your long-term health outcomes, with ongoing prescriber support throughout your treatment journey.

Next Steps: Starting Your Wegovy Journey

Begin by completing the free online assessment, which asks straightforward questions about your health, weight history, and treatment goals. Our UK prescribers review every submission individually—there's no automated approval system—ensuring genuine clinical oversight.

Once approved and your order placed, expect discreet delivery within one business day across most UK addresses. Your package includes full administration instructions, though our pharmacy team remains available by phone (+44 116 4646009) for any questions about injection technique, storage, or managing your treatment schedule.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., Rudofsky, G., Tadayon, S., Wadden, T. A., Dicker, D., & STEP 4 Investigators. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
3. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and weight loss outcomes depend on multiple factors including diet, exercise, and adherence to treatment.